The European Hematology Association (EHA)
  • Welcome
  • Introduction to CAR T cell therapy
  • Current clinical landscape for CAR T in Europe
  • Clinical and regulatory implementation of CAR T in Europe
  • Future developments
  • EHA Topics-in-Focus: Immunotherapy

The European Hematology Association (EHA)

  • Menu

Webinars


Back

Ortiz-Maldonado - Oral Flash 2.6 - Impact of immune impairment on infectious complications following ARI-0001 cell (A3B1:CD8:4-1BB:CD3Z CART19) treatment in patients with CD19+ relapsed / refractory malignancies: an analysis of an academic CART19 – Friday

Topp - Management of CRS and neurotoxicities – Saturday, session 19

EHA Executive Office - Koninginnegracht 12b, 2514 AA - The Hague, The Netherlands
Phone: +31 (0)70 3020 099 Email: info@ehaweb.org KvK-number 24334797

© Copyright 2017 - European Hematology Association All rights reserved.
Web design: Loyals